DVL2

dishevelled segment polarity protein 2, the group of PDZ domain containing|Dishevelled segment polarity proteins

Basic information

Region (hg38): 17:7225342-7234517

Links

ENSG00000004975NCBI:1856OMIM:602151HGNC:3086Uniprot:O14641AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DVL2 gene.

  • not_specified (95 variants)
  • DVL2-related_disorder (10 variants)
  • not_provided (5 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DVL2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004422.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
1
clinvar
5
missense
93
clinvar
4
clinvar
2
clinvar
99
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 93 8 3
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DVL2protein_codingprotein_codingENST00000005340 159205
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00001361.001257230251257480.0000994
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3224474670.9580.00002804747
Missense in Polyphen170212.540.799842129
Synonymous-1.142091891.110.00001211541
Loss of Function3.101433.30.4200.00000184354

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002480.000248
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00004640.0000462
European (Non-Finnish)0.0001040.0000967
Middle Eastern0.0001630.000163
South Asian0.00009810.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in the signal transduction pathways mediated by multiple Wnt genes. Participates both in canonical and non-canonical Wnt signaling by binding to the cytoplasmic C- terminus of frizzled family members and transducing the Wnt signal to down-stream effectors. Promotes internalization and degradation of frizzled proteins upon Wnt signaling. {ECO:0000250|UniProtKB:Q60838, ECO:0000269|PubMed:19252499}.;
Pathway
Gastric cancer - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Breast cancer - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Basal cell carcinoma - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Wnt signaling pathway - Homo sapiens (human);Notch signaling pathway - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);WNT-Core;Neural Crest Differentiation;Notch Signaling Pathway;Wnt Signaling Pathway;Regulation of Wnt-B-catenin Signaling by Small Molecule Compounds;ESC Pluripotency Pathways;Wnt Signaling Pathway and Pluripotency;Wnt Signaling in Kidney Disease;Type 2 papillary renal cell carcinoma;Notch Signaling Pathway;Wnt Signaling Pathway;DNA Damage Response (only ATM dependent);Signaling by WNT;Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;RHO GTPases Activate Formins;Disassembly of the destruction complex and recruitment of AXIN to the membrane;RHO GTPase Effectors;Signaling by Rho GTPases;Clathrin-mediated endocytosis;Asymmetric localization of PCP proteins;WNT5A-dependent internalization of FZD4;PCP/CE pathway;Beta-catenin independent WNT signaling;Noncanonical Wnt signaling pathway;Cargo recognition for clathrin-mediated endocytosis;Negative regulation of TCF-dependent signaling by DVL-interacting proteins;Degradation of DVL;Signaling by Hippo;Wnt;Wnt Canonical;WNT mediated activation of DVL;Degradation of beta catenin;TCF dependent signaling in response to WNT;Canonical Wnt signaling pathway;Wnt Mammals (Consensus)

Recessive Scores

pRec
0.214

Intolerance Scores

loftool
0.650
rvis_EVS
-1.21
rvis_percentile_EVS
5.69

Haploinsufficiency Scores

pHI
0.920
hipred
Y
hipred_score
0.765
ghis
0.595

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.995

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dvl2
Phenotype
embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; craniofacial phenotype;

Zebrafish Information Network

Gene name
dvl2
Affected structure
head
Phenotype tag
abnormal
Phenotype quality
decreased size

Gene ontology

Biological process
neural tube closure;positive regulation of protein phosphorylation;outflow tract morphogenesis;transcription by RNA polymerase II;segment specification;heart development;convergent extension involved in neural plate elongation;cellular protein localization;hippo signaling;non-canonical Wnt signaling pathway;positive regulation of JUN kinase activity;positive regulation of GTPase activity;canonical Wnt signaling pathway involved in regulation of cell proliferation;positive regulation of transcription, DNA-templated;positive regulation of DNA-binding transcription factor activity;protein complex oligomerization;canonical Wnt signaling pathway;Wnt signaling pathway, planar cell polarity pathway;membrane organization;positive regulation of protein tyrosine kinase activity;negative regulation of canonical Wnt signaling pathway;cochlea morphogenesis;planar cell polarity pathway involved in neural tube closure;positive regulation of neuron projection arborization;beta-catenin destruction complex disassembly
Cellular component
nucleus;nucleoplasm;cytoplasm;cytosol;aggresome;lateral plasma membrane;nuclear body;cytoplasmic vesicle;apical part of cell;clathrin-coated endocytic vesicle
Molecular function
frizzled binding;protein binding;protein kinase binding;protein domain specific binding;protein binding, bridging;identical protein binding;protein self-association;Rac GTPase binding